Strategy Opportunities Allocation Capital Process Submit a Mandate
Dubai · Palo Alto · Hong Kong

Off-Market
Capital.

A global private investor and advisory firm for founders and growth-stage operators. Disciplined capital. Boutique access. Institutional execution.

30+
Years Experience
$500M+
Under Management
20+
Portfolio Companies
4
Continents
The Witucki Philosophy

Precision Capital,
Strategic Outcomes.

We connect capital with opportunity through a structured, selective process — qualifying mandates, validating theses, and shaping clear narratives that enable efficient deployment and durable alignment.

Where capital aligns with vision. A disciplined, selective investor partnering with founders and growth-stage operators across global markets.

— Timothy Witucki, Managing Partner
Execution & Value-Add

Flexible capital.
Hands-on outcomes.

I Capital
Flexible Funding

Seed-to-growth deployment from a single-family office platform. Checks $5M to $500M, structured credit and SPVs — tailored to mandate requirements.

II Network
Ecosystem Activation

A 30-year global network of operators, co-investors, fund managers, and strategic partners — mobilized for portfolio companies at every stage.

III Operations
Hands-On Support

Shoulder-to-shoulder with founders on strategy, hiring, and governance — backed by CPAs, attorneys, bankers, and dedicated research analysts.

Featured Opportunities

Vetted mandates,
2026 deployment.

Three current opportunities — selected, structured, and ready for institutional capital.

YC-Backed Pharmacy Supply Chain · Series A
Anahad Pharma
Mumbai, India
Valuation Cap
$25M
Monthly Sales
$1M+
Growth Rate
20% QoQ
Target Reach
5,000+

Validated business model solving fragmentation in Indian pharma retail — institutional supply chain orchestration at scale.

Commercial Real Estate · Equity
Cisterra Development
San Diego, CA
Experience
20+ Yrs
Focus
Urban Core
Asset Class
Mixed-Use
Strategy
Tenant-Centric

Deep regional pedigree delivering high-value, community-integrated assets across Southern California's urban core.

Clinically Validated AI Healthcare · Early Growth
VOXEA
Stanford, CA
Technology
Voice AI
Value Cap
$100M
Application
Diagnostics
Market
Global

Turning everyday speech into a regulated diagnostic voice biomarker — Stanford-validated science for early detection.

Portfolio Allocation

Industry focus &
capital allocation.

25%
AI & Deep Tech
  • Foundational models & orchestration
  • Vertical AI applications
  • Autonomous agents & infrastructure
  • Data & compute platforms
25%
Healthcare & Pharma
  • Genomics & precision medicine
  • Digital health & diagnostics
  • Pharmacy supply chain optimisation
  • Longevity & preventative care
50%
Commercial Real Estate
  • Equity & debt for development
  • Multi-family residential
  • Industrial & logistics
  • Self-storage & specialty assets
FY 2026 Mandate Profile
18–22%
Projected Annual Returns
$5–100M
Per Mandate
$500M+
Under Management
Global Footprint

A borderless private office.

NA
North America
Palo Alto, California
New York, New York
Sheridan, Wyoming
ME
Middle East
Dubai
Free Trade Zone
 
SEA
Southeast Asia
Hong Kong
Singapore
 
EU
Europe
Selective mandates
 
 
4 Continents
Capital Markets Reach
Capital Lifecycle

Our deal appetite.

From product validation through to global scale. Flexible terms paired with operational support.

I Stage I · Validation
Seed Stage
$250K — $2M

Product-market fit validation, MVP refinement, initial core team hiring.

Hands-on strategy & network activation
II Stage II · Scale-Up
Series A / B
$2M — $10M

GTM acceleration, sales efficiency, operational infrastructure scaling.

Syndication lead & operational partner
III Stage III · Expansion
Growth Stage
$10M — $500M+

International expansion, M&A opportunities, pre-IPO readiness.

Structured capital & strategic advisory
Founder Journey

Five-step deal submission.

01
Phase 01
Pitch Submission
Intake Checklist
02
Phase 02
Review & Discovery
Engagement Memo
03
Phase 03
Intro & Negotiation
Term Sheet Support
04
Phase 04
Diligence & Packaging
Data Room Ready
05
Phase 05
Close & Support
Integration Plan
8–12 weeks
Average intake to close
5 days
Initial review timeline
100%
Process transparency
Begin the Conversation

Deal submission
& contact.

We invite CEOs, founders, and partners to begin the conversation. Submit your materials and expect a response within 5 business days.

  • Executive summary & pitch deck
  • Three-year financial projections
  • Cap table & ownership structure
  • Founder & leadership bios
  • Use-of-funds memo
Submit a Mandate
Direct Line
Timothy Witucki
Managing Partner
California 1630 North Main St, Suite 202
Walnut Creek, CA 94596
Wyoming 1309 Coffeen Ave, Suite 1200
Sheridan, WY 82801